PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
PEAR
Delisted
PEAR was delisted on the 18th of April, 2023.
18 hedge funds and large institutions have $26.9M invested in Pear Therapeutics, Inc. Class A Common Stock in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
18
Holders Change
+18
Holders Change %
–
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$6.87M |
2 |
SCM
2
Saba Capital Management
New York
|
$6.38M |
3 |
UOC
3
UBS O'Connor
Chicago,
Illinois
|
$2.4M |
4 |
OCM
4
Oribel Capital Management
New York
|
$2.05M |
5 |
SC
5
Sculptor Capital
New York
|
$1.93M |
Top Sellers
No sellers this quarter